Cargando…
Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats
Kynurenic acid (KYNA) is an endogenous catabolite of tryptophan that has been found to demonstrate neuroprotective properties in psychiatric disorders. Recently, accumulating data have suggested that KYNA may also play a significant role in various metabolic diseases by stimulating energy metabolism...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328841/ https://www.ncbi.nlm.nih.gov/pubmed/37424591 http://dx.doi.org/10.1016/j.heliyon.2023.e17733 |